321 related articles for article (PubMed ID: 29872429)
21. Immunity to influenza.
Schild GC; Oxford JS; Virelizier JL
Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
[TBL] [Abstract][Full Text] [Related]
22. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
[TBL] [Abstract][Full Text] [Related]
23. Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.
Rowntree LC; Nguyen THO; Halim H; Purcell AW; Rossjohn J; Gras S; Kotsimbos TC; Mifsud NA
J Immunol; 2018 Jun; 200(12):3993-4003. PubMed ID: 29735483
[TBL] [Abstract][Full Text] [Related]
24. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S; Kurata T
Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
[TBL] [Abstract][Full Text] [Related]
25. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.
Jegaskanda S; Reading PC; Kent SJ
J Immunol; 2014 Jul; 193(2):469-75. PubMed ID: 24994909
[TBL] [Abstract][Full Text] [Related]
26. Influenza virus N-linked glycosylation and innate immunity.
York IA; Stevens J; Alymova IV
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30552137
[TBL] [Abstract][Full Text] [Related]
27. From Original Antigenic Sin to the Universal Influenza Virus Vaccine.
Henry C; Palm AE; Krammer F; Wilson PC
Trends Immunol; 2018 Jan; 39(1):70-79. PubMed ID: 28867526
[TBL] [Abstract][Full Text] [Related]
28. [Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009].
Naĭkhin AN; Donina SA; Petukhova GD; Koren'kov EM; Doroshenko EM; Grigor'eva EP; Suvorova MA; Rudenko LG
Vopr Virusol; 2013; 58(2):38-42. PubMed ID: 23785769
[TBL] [Abstract][Full Text] [Related]
29. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
[TBL] [Abstract][Full Text] [Related]
30. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
31. Toward a broadly protective influenza vaccine.
Doherty PC; Kelso A
J Clin Invest; 2008 Oct; 118(10):3273-5. PubMed ID: 18802488
[TBL] [Abstract][Full Text] [Related]
32. Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract.
Marois I; Cloutier A; Garneau É; Richter MV
J Leukoc Biol; 2012 Jul; 92(1):107-21. PubMed ID: 22504848
[TBL] [Abstract][Full Text] [Related]
33. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
[TBL] [Abstract][Full Text] [Related]
34. Systems Immunology: Revealing Influenza Immunological Imprint.
Tomic A; Pollard AJ; Davis MM
Viruses; 2021 May; 13(5):. PubMed ID: 34065617
[TBL] [Abstract][Full Text] [Related]
35. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.
van Riet E; Ainai A; Suzuki T; Hasegawa H
Vaccine; 2012 Aug; 30(40):5893-900. PubMed ID: 22835738
[TBL] [Abstract][Full Text] [Related]
36. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
37. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
[TBL] [Abstract][Full Text] [Related]
38. Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection.
Pichyangkul S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Im-Erbsin R; Boonnak K; Thitithayanont A; Jongkaewwattana A; Wiboon-ut S; Mongkolsirichaikul D; Mahanonda R; Spring M; Chuang I; Mason CJ; Saunders DL
J Immunol; 2015 Nov; 195(9):4378-86. PubMed ID: 26408671
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
[TBL] [Abstract][Full Text] [Related]
40. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
